Clinical Trial Update: Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 study comparing insulin detemir with NPH insulin in children and adolescents with Type 1 diabetes has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED